Agree with ocean. As an example, when a company like gwph announces their epilepsy mmj is awaiting government approval, they get traded up to over a $1B market cap, even with a negative net income. When Apple announces an exciting new device, pps will rise in anticipation of new revenue, etc.

Anticipating profit can way overshoot the reality. It happens all the time where a very profitable company, like Apple, can make a shet load of profit, but it's less than expected, and despite the strong earnings the pps can/does drop.

Long story short, the anticipation after license should drive fitx up and bring new investors into the mix. There are a lot of catalysts that *could* propel fitx wayyyy above where it would be if it were an established business in an established industry.